Characterization of plant-derived saponin natural products against candida albicans

ACS Chemical Biology

Volumn 5, Issue 3, 2010, Pages 321-332

  Coleman, Jeffrey J ^a   Okoli, Ikechukwu ^a   Tegos, George P ^a,b   Holson, Edward B ^c   Wagner, Florence F ^c   Hamblin, Michael R ^a,b,d   Mylonakis, Eleftherios ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c BROAD INSTITUTE OF MIT AND HARVARD   (United States)

^d HARVARD MIT DIVISION OF HEALTH SCIENCES AND TECHNOLOGY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGINOSIDE; AMPHOTERICIN B; ANTIFUNGAL AGENT; CHOLESTEROL; ERGOSTEROL; FLUCONAZOLE; PHOTOSENSITIZING AGENT; SAKURASOSAPONIN; SAPONIN DERIVATIVE; SODIUM CHLORIDE; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIFUNGAL RESISTANCE; ARTICLE; BIOFILM; CAENORHABDITIS ELEGANS; CANDIDA ALBICANS; CELL MEMBRANE PERMEABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DRUG BINDING; DRUG PENETRATION; ERYTHROCYTE; FUNGAL CELL; FUNGUS HYPHAE; FUNGUS ISOLATION; HEMOLYSIS; HIGH THROUGHPUT SCREENING; HUMAN; MINIMUM INHIBITORY CONCENTRATION; NEMATODE; NONHUMAN; OSMOTIC STRESS; PHOTODYNAMICS; PRIORITY JOURNAL; STRUCTURE ACTIVITY RELATION; SURVIVAL;

ANIMALS; ANTIFUNGAL AGENTS; CANDIDA ALBICANS; CANDIDIASIS; DRUG INTERACTIONS; ERYTHROCYTES; FLUCONAZOLE; HEMOLYSIS; HUMANS; MICROBIAL SENSITIVITY TESTS; OSMOTIC PRESSURE; PHOTOCHEMISTRY; PLANT EXTRACTS; SAPONINS; SHEEP;

CAENORHABDITIS ELEGANS; CANDIDA ALBICANS; FUNGI;

EID: 77949786649     PISSN: 15548929     EISSN: 15548937     Source Type: Journal    
DOI: 10.1021/cb900243b     Document Type: Article

References (44)

1. Edmond, M. B., Wallace, S. E., McClish, D. K., Pfaller, M. A., Jones, R. N., and Wenzel, R. P. (1999) Nosocomial bloodstream infections in United States hospitals: a three year analysis, Clin. Infect. Dis. 29, 239-244.
2. Pfaller, M. A., and Diekema, D. J. (2007) Epidemiology of invasive candidiasis: a persistent public health problem, Clin. Microbiol. Rev. 20, 133-163.
3. Laupland, K. B., Zygun, D. A., Davies, H. D., Church, D. L., Louie, T. J., and Doig, C. J. (2002) Incidence and risk factors for acquiring nosocomial urinary tract infection in the critically ill, J. Crit. Care 17, 50-57.
4. Paulitsch, A., Weger, W., Ginter-Hanselmayer, G., Marth, E., and Buzina, W. (2006) A 5-year (2000-2004) epidemiological survey of Candida and non-Candida yeast species causing vulvovaginal candidiasis in Graz, Austria, Mycoses 49, 471-475.
5. Corsello, S., Spinillo, A., Osnengo, G., Penna, C., Guaschino, S., Beltrame, A., Blasi, N., and Festa, A. (2003) An epidemiological survey of vulvovaginal candidiasis in Italy, Eur. J. Obstet. Gynecol. Reprod. Biol. 110, 66-72.
6. Ventolini, G., Baggish, M. S., and Walsh, P. M. (2006) Vulvovaginal candidiasis from non-albicans species: retrospective study of recurrence rate after fluconazole therapy, J. Reprod. Med. 51, 475-478.
7. Kumamoto, C. A., and Vinces, M. D. (2005) Alternative Candida albicans lifestyles: growth on surfaces, Annu. Rev. Microbiol. 59, 113-133.
8. Li, X., Yan, Z., and Xu, J. (2003) Quantitative variation of biofilms among strains in natural populations of Candida albicans, Microbiology 149, 353-362.
9. Berman, J., and Sudbery, P. E. (2002) Candida albicans: A molecular revolution built on lessons from budding yeast, Nat. Rev. Genet. 3, 918-932.
10. Kobayashi, S. D., and Cutler, J. E. (1998) Candida albicans hyphal formation and virulence: is there a clearly defined role? Trends Microbiol. 6, 92-94.
11. Kojic, E. M., and Darouiche, R. O. (2004) Candida infections of medical devices, Clin. Microbiol. Rev. 17, 255-267.
12. Ramage, G., Martínez, J. P., and López-Ribot, J. L. (2006) Candida biofilms on implanted biomaterials: a clinically significant problem, FEMS Yeast Res. 6, 979-986.
13. Spanakis, E., Aperis, G., and Mylonakis, E. (2006) New agents for the treatment of fungal infections: clinical efficacy and gaps in coverage, Clin. Infect. Dis. 43, 1060-1068.
14. Trejo, W. H., and Bennett, R. E. (1963) Streptomyces nodosus sp. N, the amphotericin-producing organism, J. Bacteriol. 85, 436-439.
15. Dixon, R. A. (2001) Natural products and plant disease resistance, Nature 411, 843-847.
16. Breger, J., Fuchs, B. B., Aperis, G., Moy, T. I., Ausubel, F. M., and Mylonakis, E. (2007) Antifungal chemical compounds identified using a C. elegans pathogenicity assay, PLoS Pathog. 3, e18.
17. Okoli, I., Coleman, J. J., Tempakakis, E., An, W. F., Holson, E., Wagner, F., Conery, A. L., Larkins-Ford, J., Wu, G., Stern, A., Ausubel, F. M., and Mylonakis, E. (2009) Identification of antifungal compounds active against Candida albicans using an improved high-throughput Caenorhabditis elegans assay, PLoS ONE 4, e7025.
18. Sata, N., Matsunaga, S., Fusetani, N., Nishikawa, H., Takamura, S., and Saito, T. (1998) New antifungal and cytotoxic steroidal saponins from the bulbs of an elephant garlic mutant, Biosci., Biotechnol., Biochem. 62, 1904-1911.
19. Ohtani, K., Mavi, S., and Hostettmann, K. (1993) Molluscicidal and antifungal triterpenoid saponins from Rapanea melanophloeos leaves, Phytochemistry 33, 83-86.
20. Carotenuto, A., Fattorusso, E., Lanzotti, V., and Magno, S. (1999) Spirostanol saponins of Allium porrum L, Phytochemistry 51, 1077-1082.
21. Germonprez, N., Maes, L., Van Puyvelde, L., Van Tri, M., Tuan, D. A., and De Kimpe, N. (2005) In vitro and in vivo anti-leishmanial activity of triterpenoid saponins isolated from Maesa balansae and some chemical derivatives, J. Med. Chem. 48, 32-37.
22. Herlt, A. J., Mander, L. N., Pongoh, E., Rumampuk, R. J., and Tarigan, P. (2002) Two major saponins from seeds of Barringtonia asiatica: putative antifeedants toward Epilachna sp. larvae, J. Nat. Prod. 65, 115-120.
23. Liu, H. W., Yao, X. S., Wang, N. L., and Cai, G. P. (2006) A new triterpenoid spaonin isolated from the seeds of Aesculus assamica Griff, Chin. Chem. Lett. 17, 211-214.
24. Sun, H.-X., Xie, Y., and Ye, Y.-P. (2009) Advances in saponin-based adjuvants, Vaccine 27, 1787-1796.
25. Francis, G., Kerem, Z., Makkar, H. P. S., and Becker, K. (2002) The biological action of saponins in animal systems: a review, Br. J. Nutr. 88, 587-605.
26. Zhang, J.-D., Cao, Y.-B., Xu, Z., Sun, H.-H., An, M.-M., Yan, L., Chen, H.-S., Gao, P.-H., Wang, Y., Jia, X.-M., and Jiang, Y.-Y. (2005) In vitro and in vivo antifungal activities of the eight steroid saponins from Tribulus terrestris L. with potent activity against fluconazoleresistant fungal, Biol. Pharm. Bull. 28, 2211-2215.
27. d'Enfert, C. (2006) Biofilms and their role in the resistance of pathogenic Candida to antifungal agents, Curr. Drug Targets 7, 465-470.
28. Bangham, A. D., and Horne, R. W. (1962) Action of saponin on biological cell membranes, Nature 196, 952-953.
29. Glauert, A. M., Dingle, J. T., and Lucy, J. A. (1962) Action of saponin on biological cell membranes, Nature 196, 953-955.
30. Sparg, S. G., Light, M. E., and van Staden, J. (2004) Biological activities and distribution of plant saponins, J. Ethnopharmacol. 94, 219-243.
31. Takechi, M., and Tanaka, Y. (1995) Time course differences between steroid and triterpenoid saponins, Planta Med. 61, 76-77.
32. Simons, V., Morrissey, J. P., Latijnhouwers, M., Csukai, M., Cleaver, A., Yarrow, C., and Osbourn, A. (2006) Dual effects of plant steroidal alkaloids on Saccharomyces cerevisiae, Antimicrob. Agents Chemother. 50, 2732-2740.
33. Fuchs, B. B., Tegos, G. P., Hamblin, M. R., and Mylonakis, E. (2007) Susceptibility of Cryptococcus neoformans to photodynamic inactivation is associated with cell wall integrity, Antimicrob. Agents Chemother. 51, 2929-2936.
34. Demidova, T. N., and Hamblin, M. R. (2004) Photodynamic therapy tergeted to pathogens, Int. J. Immunopathol. Pharmacol. 17, 245-254.
35. Hamblin, M. R., and Hasan, T. (2004) Photodynamic therapy: a new antimicrobial approach to infectious disease? Photochem. Photobiol. Sci. 3, 436-450.
36. Tegos, G. P., and Hamblin, M. R. (2006) Phenothiazinium antimicrobial photosensitizers are substrates of bacterial multidrug resistance pumps, Antimicrob. Agents Chemother. 50, 196-203.
37. White, T. C., Holleman, S., Dy, F., Mirels, L. F., and Stevens, D. A. (2002) Resistance mechanisms in clinical isolates of Candida albicans, Antimicrob. Agents Chemother. 46, 1704-1713.
38. Osbourn, A. (1996) Saponins and plant defence-a soap story, Trends Plant Sci 1, 4-9.
39. Tampakakis, E., Okoli, I., and Mylonakis, E. (2008) A C. elegansbased, whole animal, in vivo screen for the identification of antifungal compounds, Nat. Protoc. 3, 1925-1931.
40. Davis, D., Edwards, J. E., Jr., Mitchell, A. P., and Ibrahim, A. S. (2000) Candida albicans RIM101 pH response pathway is required for hostpathogen interactions, Infect. Immun. 68, 5953-5959.
41. Moy, T. I., Ball, A. R., Anklesaria, Z., Casadei, G., Lewis, K., and Ausubel, F. M. (2006) Identification of novel antimicrobials using a liveanimal infection model, Proc. Natl. Acad. Sci. U.S.A. 103, 10414-10419.
42. Garcia-Effron, G., Park, S., and Perlin, D. S. (2009) Correlating echinocandin MIC and kinetic inhibition of fks1 mutant glucan synthases for Candida albicans: implications for interpretive breakpoints, Antimicrob. Agents Chemother. 53, 112-122.
43. National Committee for Clinical Laboratory Standards (1995) Reference method for broth dilution susceptibility testing of yeast, Tentative Standard M27-A, Villanova, PA. 44. Richard, M. L., Nobile, C. J., Bruno, V. M., and Mitchell, A. P. (2005) Candida albicans biofilm-defective mutants, Eukaryotic Cell 4, 1493-1502.
44. Tegos, G. P., Anbe, M., Yang, C., Demidova, T. N., Satti, M., Mroz, P., Janjua, S., Gad, F., and Hamblin, M. R. (2006) Protease-stable polycationic photosensitizer conjugates between polyethyleneimine and chlorin(e6) for broad-spectrum antimicrobial photoinactivation, Antimicrob. Agents Chemother. 50, 1402-1410.